Pacific Hospital Supply Co., Ltd (TPEX: 4126)
Taiwan
· Delayed Price · Currency is TWD 88.10
+0.50 (0.57%)
Sep 11, 2024, 11:12 AM CST
Pacific Hospital Supply Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 2,227 | 2,320 | 2,185 | 2,019 | 2,172 | 2,041 | Upgrade
|
| Revenue Growth (YoY) | -7.98% | 6.19% | 8.23% | -7.05% | 6.43% | 11.97% | Upgrade
|
| Cost of Revenue | 1,516 | 1,580 | 1,597 | 1,495 | 1,494 | 1,462 | Upgrade
|
| Gross Profit | 711.71 | 739.75 | 587.97 | 523.42 | 678.21 | 578.88 | Upgrade
|
| Selling, General & Admin | 173.4 | 184.31 | 187.36 | 162.72 | 192.12 | 188.92 | Upgrade
|
| Research & Development | 68.76 | 57.42 | 46.12 | 47.3 | 45.18 | 42.69 | Upgrade
|
| Operating Expenses | 242.35 | 241.73 | 233.48 | 210.02 | 237.3 | 231.61 | Upgrade
|
| Operating Income | 469.36 | 498.01 | 354.5 | 313.4 | 440.92 | 347.28 | Upgrade
|
| Interest Expense | -5.75 | -5.73 | -7.03 | -8.61 | -11.25 | -14.76 | Upgrade
|
| Interest & Investment Income | 21.76 | 17.61 | 3.72 | 0.25 | 0.69 | 1.67 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.94 | -1.65 | 37.05 | -38.51 | -20.69 | -2.85 | Upgrade
|
| Other Non Operating Income (Expenses) | 16.95 | 20.01 | 19.96 | 17.56 | 16.09 | 14 | Upgrade
|
| EBT Excluding Unusual Items | 506.25 | 528.26 | 408.19 | 284.09 | 425.76 | 345.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2 | -2.77 | 5.29 | 149.93 | -3.05 | 184.51 | Upgrade
|
| Pretax Income | 504.26 | 525.49 | 413.48 | 434.03 | 422.71 | 529.84 | Upgrade
|
| Income Tax Expense | 100.05 | 104.7 | 82.08 | 47.61 | 93.99 | 70.72 | Upgrade
|
| Net Income | 404.21 | 420.79 | 331.4 | 386.42 | 328.72 | 459.12 | Upgrade
|
| Net Income to Common | 404.21 | 420.79 | 331.4 | 386.42 | 328.72 | 459.12 | Upgrade
|
| Net Income Growth | -8.28% | 26.98% | -14.24% | 17.55% | -28.40% | 112.21% | Upgrade
|
| Shares Outstanding (Basic) | 73 | 73 | 73 | 73 | 73 | 73 | Upgrade
|
| Shares Outstanding (Diluted) | 73 | 73 | 73 | 73 | 73 | 73 | Upgrade
|
| Shares Change (YoY) | -0.02% | 0.05% | 0.06% | -0.00% | -0.02% | 0.09% | Upgrade
|
| EPS (Basic) | 5.57 | 5.80 | 4.56 | 5.32 | 4.53 | 6.32 | Upgrade
|
| EPS (Diluted) | 5.54 | 5.76 | 4.54 | 5.29 | 4.50 | 6.29 | Upgrade
|
| EPS Growth | -8.04% | 26.87% | -14.18% | 17.56% | -28.46% | 112.19% | Upgrade
|
| Free Cash Flow | 512.84 | 625.83 | 400.96 | 288.34 | 492.46 | 251.32 | Upgrade
|
| Free Cash Flow Per Share | 7.02 | 8.57 | 5.49 | 3.95 | 6.75 | 3.44 | Upgrade
|
| Dividend Per Share | 4.800 | 4.800 | 4.200 | 4.500 | 4.200 | 3.637 | Upgrade
|
| Dividend Growth | 14.29% | 14.29% | -6.67% | 7.14% | 15.47% | 25.00% | Upgrade
|
| Gross Margin | 31.95% | 31.88% | 26.91% | 25.93% | 31.23% | 28.37% | Upgrade
|
| Operating Margin | 21.07% | 21.46% | 16.22% | 15.52% | 20.30% | 17.02% | Upgrade
|
| Profit Margin | 18.15% | 18.14% | 15.17% | 19.14% | 15.14% | 22.50% | Upgrade
|
| Free Cash Flow Margin | 23.03% | 26.97% | 18.35% | 14.28% | 22.67% | 12.32% | Upgrade
|
| EBITDA | 595.13 | 624.99 | 487.38 | 458.58 | 594.59 | 501.42 | Upgrade
|
| EBITDA Margin | 26.72% | 26.94% | 22.31% | 22.72% | 27.38% | 24.57% | Upgrade
|
| D&A For EBITDA | 125.77 | 126.98 | 132.89 | 145.18 | 153.68 | 154.14 | Upgrade
|
| EBIT | 469.36 | 498.01 | 354.5 | 313.4 | 440.92 | 347.28 | Upgrade
|
| EBIT Margin | 21.07% | 21.46% | 16.22% | 15.52% | 20.30% | 17.02% | Upgrade
|
| Effective Tax Rate | 19.84% | 19.92% | 19.85% | 10.97% | 22.23% | 13.35% | Upgrade
|
| Revenue as Reported | - | - | - | 2,019 | 2,172 | 2,041 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.